466 related articles for article (PubMed ID: 2931452)
21. A stathmokinetic study of B lymphocytopoiesis in rat bone marrow: proliferation of cells containing cytoplasmic mu-chains, terminal deoxynucleotidyl transferase and carrying HIS24 antigen.
Deenen GJ; Hunt SV; Opstelten D
J Immunol; 1987 Aug; 139(3):702-10. PubMed ID: 3110280
[TBL] [Abstract][Full Text] [Related]
22. Membrane CD22 defines circulating myeloma-related cells as mature or later B cells.
Perfetti V; Vignarelli MC; Bellotti V; Glennie MJ; Zorzoli I; Ubbiali P; Obici L; Massa M; Ippoliti G; Ascari E; Merlini G
Lab Invest; 1997 Oct; 77(4):333-44. PubMed ID: 9354768
[TBL] [Abstract][Full Text] [Related]
23. Antigens on human plasma cells identified by monoclonal antibodies.
Anderson KC; Park EK; Bates MP; Leonard RC; Hardy R; Schlossman SF; Nadler LM
J Immunol; 1983 Mar; 130(3):1132-8. PubMed ID: 6401780
[TBL] [Abstract][Full Text] [Related]
24. Comparison of the expression of terminal deoxynucleotidyl transferase and common acute lymphoblastic leukemia antigen in selected hematologic malignancies.
Bodner SM; Casavant CH; McHugh TM; Stites DP
Diagn Immunol; 1985; 3(3):139-44. PubMed ID: 2932276
[TBL] [Abstract][Full Text] [Related]
25. Modulation of CALLA (CD10) antigen on cultured ALL (REH) cells: effect of various modulators.
Chorváth B; Sedlák J; Duraj J; Plesková I; Dubovský P; Augustinová M; Doxiadis I; Grosse-Wilde H
Neoplasma; 1990; 37(6):609-18. PubMed ID: 2148811
[TBL] [Abstract][Full Text] [Related]
26. Normal and neoplastic plasma cell membrane phenotype: studies with new monoclonal antibodies.
Tazzari PL; Gobbi M; Dinota A; Bontadini A; Grassi G; Cerato C; Cavo M; Pileri S; Caligaris-Cappio F; Tura S
Clin Exp Immunol; 1987 Oct; 70(1):192-200. PubMed ID: 3319299
[TBL] [Abstract][Full Text] [Related]
27. Genotypic characterization of common acute lymphoblastic leukemia may improve the phenotypic classification.
Foa R; Migone N; Fierro MT; Basso G; Lusso P; Putti MC; Giubellino MC; Saitta M; Miniero R; Casorati G
Exp Hematol; 1987 Oct; 15(9):942-5. PubMed ID: 3115807
[TBL] [Abstract][Full Text] [Related]
28. Phenotypic heterogeneity in aneuploid multiple myeloma indicates pre-B cell involvement.
Epstein J; Barlogie B; Katzmann J; Alexanian R
Blood; 1988 Apr; 71(4):861-5. PubMed ID: 2451550
[TBL] [Abstract][Full Text] [Related]
29. CD10 and CD44 genes of leukemic cells and malignant cell lines show no evidence of transformation-related alterations.
Kee BL; Dadi HK; Tran-Paterson R; Quackenbush EJ; Andrulis IL; Letarte M
J Cell Physiol; 1991 Sep; 148(3):414-20. PubMed ID: 1833412
[TBL] [Abstract][Full Text] [Related]
30. B-lymphocyte associated differentiation antigen expression by 'non-B, non-T' acute lymphoblastic leukemia.
Flug F; Dodson L; Wolff J; Guarini L; Rausen A; Wang CY; Knowles DM
Leuk Res; 1985; 9(8):1051-8. PubMed ID: 2931557
[TBL] [Abstract][Full Text] [Related]
31. CD19 and immunophenotype of bone marrow plasma cells in monoclonal gammopathy of undetermined significance.
Zandecki M; Facon T; Bernardi F; Izydorczyk V; Dupond L; François M; Reade R; Iaru T; Bauters F; Cosson A
J Clin Pathol; 1995 Jun; 48(6):548-52. PubMed ID: 7545187
[TBL] [Abstract][Full Text] [Related]
32. [Prognostic value of the ratio of bone marrow plasma cells in multiple myeloma].
Pasqualetti P; Colantonio D; Casale R
Minerva Med; 1990 Mar; 81(3):129-33. PubMed ID: 2320280
[TBL] [Abstract][Full Text] [Related]
33. Abnormal in vitro differentiation of clonogenic B-cells in common acute lymphoblastic leukemia in complete remission. A marker for minimal residual disease?
Bréard J; Mathé G; Consolini R
Bull Soc Sci Med Grand Duche Luxemb; 1989; 126(1):47-50. PubMed ID: 2525967
[TBL] [Abstract][Full Text] [Related]
34. [CALLA-positive leukemic multiple myeloma of IgA-kappa type].
Matsumura I; Miyata S; Tago H; Kawakami F; Okuno G; Tominaga N; Katagiri S; Kanayama Y; Yonezawa T
Rinsho Ketsueki; 1989 Apr; 30(4):491-6. PubMed ID: 2504977
[TBL] [Abstract][Full Text] [Related]
35. Immunobiologic differences between normal and leukemic human B-cell precursors.
Uckun FM; Ledbetter JA
Proc Natl Acad Sci U S A; 1988 Nov; 85(22):8603-7. PubMed ID: 2460871
[TBL] [Abstract][Full Text] [Related]
36. Bone marrow kinetic studies on three patients with myelomatosis. Indications for malignant proliferation within both the plasma cell and lymphoid cell compartments.
Mellstedt H; Killander D; Pettersson D
Acta Med Scand; 1977; 202(5):413-7. PubMed ID: 335796
[TBL] [Abstract][Full Text] [Related]
37. Peanut agglutinin in combination with CD19 monoclonal antibody has potential as a purging agent in myeloma.
Rhodes EG; Baker P; Rhodes JM; Davies JM; Cawley JC
Exp Hematol; 1991 Sep; 19(8):833-7. PubMed ID: 1714405
[TBL] [Abstract][Full Text] [Related]
38. [Phenotypic analysis of myeloma cells].
Mihara K; Harada H; Kawano MM
Nihon Rinsho; 1995 Mar; 53(3):574-9. PubMed ID: 7699888
[TBL] [Abstract][Full Text] [Related]
39. Subpopulations of common acute lymphoblastic leukemia antigen-positive lymphoid cells in normal bone marrow identified by hematopoietic differentiation antigens.
Ryan D; Kossover S; Mitchell S; Frantz C; Hennessy L; Cohen H
Blood; 1986 Aug; 68(2):417-25. PubMed ID: 2942198
[TBL] [Abstract][Full Text] [Related]
40. Heterogeneity of childhood acute lymphoblastic leukemia (ALL): monoclonal antibodies phenotyping and induction of differentiation in vitro.
Umiel T; Luria D; Stark B; Cohen IJ; Gozes Y; Kobiler D; Kodman Y; Grunspan A; Dvir A; Yaniv I
Leukemia; 1988 Dec; 2(12 Suppl):88S-96S. PubMed ID: 3264367
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
